Jeena Sikho Lifecare (NSE:JSLL) Operating Income: ₹3,017 Mil (TTM As of Mar. 2026)


NSE:JSLL Jeena Sikho Lifecare Ltd NSE:JSLL
91 GF Score
Price ₹586.90
GF Value ₹771.54
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jeena Sikho Lifecare Operating Income?

Jeena Sikho Lifecare NSE:JSLL -2.55% 91 Operating Income is ₹3,017 Mil as of Mar. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹771.54 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Jeena Sikho Lifecare's Operating Income for the three months ended in Mar. 2026 was ₹615 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,017 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Jeena Sikho Lifecare's Operating Income for the three months ended in Mar. 2026 was ₹615 Mil. Jeena Sikho Lifecare's Revenue for the three months ended in Mar. 2026 was ₹2,156 Mil. Therefore, Jeena Sikho Lifecare's Operating Margin % for the quarter that ended in Mar. 2026 was 28.55%.

Good Sign:

Jeena Sikho Lifecare Ltd operating margin is expanding. Margin expansion is usually a good sign.

Jeena Sikho Lifecare's 5-Year average Growth Rate for Operating Margin % was 29.50% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jeena Sikho Lifecare's annualized ROC % for the quarter that ended in Mar. 2026 was 43.53%. Jeena Sikho Lifecare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 94.45%.

Jeena Sikho Lifecare  (NSE:JSLL) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Jeena Sikho Lifecare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2461.488 * ( 1 - 26.38% )/( (0 + 4163.064)/ 1 )
=1812.1474656/4163.064
=43.53 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6742.416 - 312.97 - ( 2266.382 - max(0, 1049.849 - 3408.671+2266.382))
=4163.064

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Jeena Sikho Lifecare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2598.124/( ( (0 + max(0, 0)) + (2342.808 + max(407.941, 0)) )/ 1 )
=2598.124/( ( 0 + 2750.749 )/ 1 )
=2598.124/2750.749
=94.45 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(699.291 + 202.182 + 240.816) - (312.97 + 0 + 421.378)
=407.941

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Jeena Sikho Lifecare's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=615.372/2155.532
=28.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Jeena Sikho Lifecare Operating Income Related Terms

Jeena Sikho Lifecare Operating Income Historical Data

* Premium members only.

The historical data trend for Jeena Sikho Lifecare's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeena Sikho Lifecare Operating Income Chart

Jeena Sikho Lifecare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Income
Get a 7-Day Free Trial 147.86 462.42 879.11 1,114.97 3,017.31

Jeena Sikho Lifecare Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 367.42 691.01 816.28 894.65 615.37
NSE:JSLL
91GF Score
Jeena Sikho Lifecare Ltd NSE:JSLL
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeena Sikho Lifecare Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,017 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of ₹3,017 Mil mean?
Jeena Sikho Lifecare (NSE:JSLL) has a Operating Income of ₹3,017 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Jeena Sikho Lifecare and its competitors.
Is Jeena Sikho Lifecare's Operating Income too high?
Jeena Sikho Lifecare's current Operating Income is ₹3,017 Mil. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Operating Income compare to HCA and THC?
Jeena Sikho Lifecare's Operating Income of ₹3,017 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Healthcare Providers & Services company?
A good Operating Income depends on the Healthcare Providers & Services industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Jeena Sikho Lifecare and its competitors. Jeena Sikho Lifecare's current Operating Income is ₹3,017 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.54, compared to a current price of ₹586.90 — trading 23.9% below its estimated fair value. The current Operating Income is ₹3,017 Mil. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Operating Income is ₹3,017 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?

Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued. The current stock price of ₹586.90 is trading 23.9% below its estimated GF Value™ of ₹771.54. GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.

Key valuation signals for NSE:JSLL:

  • Operating Income: ₹3,017 Mil
  • GF Value™: ₹771.54 vs. price of ₹586.90 (23.9% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jeena Sikho Lifecare Business Description

Other Exchanges 544476:India
Address Kalgidhar Enclave, SCO 11 First Floor, Mohali, Zirakpur, PB, IND, 140604
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score

Get the complete analysis for NSE:JSLL

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹586.90
Price
₹771.54
GF Value